| Year |
Citation |
Score |
| 2008 |
Graves CW, Philips ST, Bradley SV, Oravecz-Wilson KI, Li L, Gauvin A, Ross TS. Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues. Cancer Research. 68: 1064-73. PMID 18281481 DOI: 10.1158/0008-5472.Can-07-5892 |
0.677 |
|
| 2007 |
Bradley SV, Smith MR, Hyun TS, Lucas PC, Li L, Antonuk D, Joshi I, Jin F, Ross TS. Aberrant Huntingtin interacting protein 1 in lymphoid malignancies. Cancer Research. 67: 8923-31. PMID 17875735 DOI: 10.1158/0008-5472.Can-07-2153 |
0.776 |
|
| 2007 |
Bradley SV, Hyun TS, Oravecz-Wilson KI, Li L, Waldorff EI, Ermilov AN, Goldstein SA, Zhang CX, Drubin DG, Varela K, Parlow A, Dlugosz AA, Ross TS. Degenerative phenotypes caused by the combined deficiency of murine HIP1 and HIP1r are rescued by human HIP1. Human Molecular Genetics. 16: 1279-92. PMID 17452370 DOI: 10.1093/Hmg/Ddm076 |
0.792 |
|
| 2007 |
Bradley SV, Holland EC, Liu GY, Thomas D, Hyun TS, Ross TS. Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor. Cancer Research. 67: 3609-15. PMID 17440072 DOI: 10.1158/0008-5472.Can-06-4803 |
0.758 |
|
| 2006 |
Smith MR, Joshi I, Jin F, Bradley SV, Ross TS. Role of Huntingtin Interacting Protein HIP-1 in Non-Hodgkin’s Lymphoma. Blood. 108: 2384-2384. DOI: 10.1182/blood.v108.11.2384.2384 |
0.711 |
|
| 2005 |
Bradley SV, Oravecz-Wilson KI, Bougeard G, Mizukami I, Li L, Munaco AJ, Sreekumar A, Corradetti MN, Chinnaiyan AM, Sanda MG, Ross TS. Serum antibodies to huntingtin interacting protein-1: a new blood test for prostate cancer. Cancer Research. 65: 4126-33. PMID 15899803 DOI: 10.1158/0008-5472.Can-04-4658 |
0.689 |
|
| 2004 |
Kalli KR, Bradley SV, Fuchshuber S, Conover CA. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer. Gynecologic Oncology. 94: 705-12. PMID 15350362 DOI: 10.1016/J.Ygyno.2004.05.059 |
0.349 |
|
| 2004 |
Hyun TS, Li L, Oravecz-Wilson KI, Bradley SV, Provot MM, Munaco AJ, Mizukami IF, Sun H, Ross TS. Hip1-related mutant mice grow and develop normally but have accelerated spinal abnormalities and dwarfism in the absence of HIP1. Molecular and Cellular Biology. 24: 4329-40. PMID 15121852 DOI: 10.1128/Mcb.24.10.4329-4340.2004 |
0.772 |
|
| 2004 |
Hyun TS, Rao DS, Saint-Dic D, Michael LE, Kumar PD, Bradley SV, Mizukami IF, Oravecz-Wilson KI, Ross TS. HIP1 and HIP1r stabilize receptor tyrosine kinases and bind 3-phosphoinositides via epsin N-terminal homology domains. The Journal of Biological Chemistry. 279: 14294-306. PMID 14732715 DOI: 10.1074/Jbc.M312645200 |
0.758 |
|
| 2003 |
Rao DS, Bradley SV, Kumar PD, Hyun TS, Saint-Dic D, Oravecz-Wilson K, Kleer CG, Ross TS. Altered receptor trafficking in Huntingtin Interacting Protein 1-transformed cells. Cancer Cell. 3: 471-82. PMID 12781365 DOI: 10.1016/S1535-6108(03)00107-7 |
0.767 |
|
| 2001 |
Rao DS, Chang JC, Kumar PD, Mizukami I, Smithson GM, Bradley SV, Parlow AF, Ross TS. Huntingtin interacting protein 1 is a clathrin coat binding protein required for differentiation of late spermatogenic progenitors Molecular and Cellular Biology. 21: 7796-7806. PMID 11604514 DOI: 10.1128/Mcb.21.22.7796-7806.2001 |
0.775 |
|
| 1998 |
Conover CA, Hartmann LC, Bradley S, Stalboerger P, Klee GG, Kalli KR, Jenkins RB. Biological characterization of human epithelial ovarian carcinoma cells in primary culture: the insulin-like growth factor system. Experimental Cell Research. 238: 439-49. PMID 9473353 DOI: 10.1006/Excr.1997.3861 |
0.351 |
|
| Show low-probability matches. |